GBT — Guerbet SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual income statement for Guerbet SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	712	732	753	786	841
Cost of Revenue
Gross Profit	545	539	579	610	652
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	670	693	771	747	792
Operating Profit	41.9	38.7	-18.2	38.7	49.6
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	22.2	29	-28.4	30.8	19.3
Provision for Income Taxes
Net Income After Taxes	18.2	32.6	-41.1	22.2	13.5
Minority Interest
Net Income Before Extraordinary Items
Net Income	18.2	32.6	-41.1	23.9	16.1
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	17.7	32.6	-41.1	22.2	13.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.46	2.62	-0.112	1.78	1.02
Dividends per Share